3',5'-DICHLORO-2,2,2,4'-TETRAFLUOROACETOPHENONE, 97.0%, 5g

N-methyl-4-morpholin-4-ylbutan-1-amine, 95.0%, 250mg

1-(4-Bromo-3-nitrophenyl)butan-1-one, 98%, 5g

Infinity corrected plan phase S40x/0.65 objective. Working distance 0.36 mm

1-(6-Ethynylpyridin-2-yl)ethanone, 98%, 250mg

2,4,6-Trimethoxyaniline, 97.0%, 250mg

3-Iodothiophene-2-carboxylic acid, 95.0%, 1g

2-chloro-6-(1H-1,2,3,4-tetrazol-5-yl)aniline, 97, 500mg

(4-CYCLOPROPYLTHIAZOL-2-YL)METHANOL, 95.0%, 250mg

1-Methyl-1H-pyrrolo[2,3-b]pyridin-4-amine, 95.0%, 100mg

3'-Bromo-4'-methoxy-2,2,2-trifluoroacetophenone, 95.0%, 250mg

AM580>98.0%(HPLC)25mg

Ethyl 2,4-Dichloropyrimidine-5-carboxylate>98.0%(GC)5g